Stay updated on Calaspargase Pegol in Adult ALL: Clinical Trial
Sign up to get notified when there's something new on the Calaspargase Pegol in Adult ALL: Clinical Trial page.

Latest updates to the Calaspargase Pegol in Adult ALL: Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov footer release label changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe study record was updated on 2026-10-29, showing the trial as terminated by sponsor decision and its results as posted rather than submitted.SummaryDifference0.6%

- Check28 days agoChange DetectedA site-wide notice was added about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.6%

- Check35 days agoChange DetectedThe footer now identifies the website as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check42 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check49 days agoChange DetectedA new version dated 2026-09-04 records changes to the study status, eligibility, outcome measures, participant flow, baseline characteristics, adverse events, and other results-related sections. Its quality-control review has not concluded, and it was returned on 2026-09-29.SummaryDifference1.0%

Stay in the know with updates to Calaspargase Pegol in Adult ALL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Calaspargase Pegol in Adult ALL: Clinical Trial page.